Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food

This article was originally published in The Tan Sheet

Executive Summary

FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000

You may also be interested in...



FDA Assessing Capability To Boost Surveillance Of Indian, Chinese OTC Firms

FDA is gathering information that targets tightening regulation of Indian and Chinese OTC, nutritional and traditional medicine manufacturers that use a registration loophole to export products to the U.S. under less stringent oversight.

FDA Assessing Capability To Boost Surveillance Of Indian, Chinese OTC Firms

FDA is gathering information that targets tightening regulation of Indian and Chinese OTC, nutritional and traditional medicine manufacturers that use a registration loophole to export products to the U.S. under less stringent oversight.

FDA Assessing Capability To Boost Surveillance Of Indian, Chinese OTC Firms

FDA is gathering information that targets tightening regulation of Indian and Chinese OTC, nutritional and traditional medicine manufacturers that use a registration loophole to export products to the U.S. under less stringent oversight.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel